戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                We conducted a retrospective, multiinstitutional analysis of adult (>=18-years-old) pa
2 n the interests and varied background of the multiinstitutional and international group of authors.
3 look to further test these models in larger, multiinstitutional cohorts.
4 , and fetal alcohol syndrome, in addition to multiinstitutional collaborative programs for mapping th
5                                              Multiinstitutional collaborative studies are needed to h
6                 We encourage the creation of multiinstitutional communities to work collaboratively t
7  Southwest Oncology Group (SWOG), a national multiinstitutional consortium that includes both academi
8  prospective, randomized trials conducted by multiinstitutional cooperative groups have resulted in t
9                                We examined a multiinstitutional data base to reevaluate the risk amon
10 he field that, if followed, would facilitate multiinstitutional data sharing and allow for the collec
11 Both of these obstacles could be overcome by multiinstitutional data sharing.
12 e intent for small HCC was identified from a multiinstitutional database.
13 Mammalian Gene Collection (MGC) Program is a multiinstitutional effort to identify and sequence a cDN
14                                   This large multiinstitutional experience confirms the feasibility,
15  but should instead rely on institutional or multiinstitutional futility policies.
16                    In this largest published multiinstitutional longitudinal CMR evaluation of confir
17            We present the first prospective, multiinstitutional, nationwide, clinically rich, bariatr
18 res can be used as valid indexes of IPF in a multiinstitutional nonspirometrically controlled study.
19 ontinued evolution of a meaningful method of multiinstitutional outcomes analysis for congenital and
20 e data are based on a subset of cases from a multiinstitutional ovarian cancer trial conducted by the
21 lt phase I trials, include the necessity for multiinstitutional participation and their higher starti
22                                            A multiinstitutional phase II clinical trial was conducted
23 t Oncology Group (SWOG) recently conducted a multiinstitutional phase II trial to determine the compl
24 ion from 10 sites enrolled in a large-scale, multiinstitutional, randomized controlled clinical trial
25    Neuroimaging has become a major focus for multiinstitutional research in progressive changes in br
26 centers in New England collaborated for this multiinstitutional retrospective study of 126 PAK transp
27                                         This multiinstitutional review of a large cohort of patients
28 high thrombosis rates are not supported by a multiinstitutional review of laparoscopic right donor ne
29                                              Multiinstitutional studies, ideally randomized, continue
30                                              Multiinstitutional studies, randomized when able, are ne
31                                              Multiinstitutional studies, randomized when practical, w
32                            In a prospective, multiinstitutional study during a 22-month period at fou
33 nalysis was performed of a large prospective multiinstitutional study involving 226 surgeons.
34 Breast Cancer Sentinel Lymph Node Study is a multiinstitutional study involving 229 surgeons.
35 e Breast Cancer Sentinel Lymph Node Study, a multiinstitutional study involving 99 surgeons.
36 al perforation has precluded a randomized or multiinstitutional study of this condition.
37                                   This was a multiinstitutional study within the CCG.
38 waapenewin Akino'maagewin trial, which was a multiinstitutional trial for First Nations adults that w
39                                   This was a multiinstitutional trial of the chimeric anti-CD20 antib
40                               A prospective, multiinstitutional trial was initiated in 1991 to examin
41 raging to warrant confirmation in randomized multiinstitutional trials.